Beruflich Dokumente
Kultur Dokumente
a r t i c l e
i n f o
Article history:
Received 2 October 2013
Accepted 3 December 2013
Keywords:
total knee arthroplasty
continuous passive motion
CPM
knee arthroplasty
knee replacement
postoperative rehabilitation
a b s t r a c t
We conducted a randomized, controlled trial to determine the efcacy of CPM following total knee arthroplasty (TKA). Postoperative outcomes of interest were: swelling, drop in hemoglobin, self-reported pain
scores, range of motion, and hospital length of stay. A total of 160 subjects were randomized into one of three
treatment groups: CPM device on and moving from the immediate post-operative period, CPM device on and
stationary at 90 degree exion for the rst night and then moving throughout the rest of their stay, and no
CPM (N = 55, 51, and 54, respectfully). Subjects were followed during the rst and second postoperative day
until their rst follow-up appointment approximately 34 weeks post-operatively. Cost of CPM was further
evaluated. CPM provided no benet to patients recovering from TKA.
2014 Elsevier Inc. All rights reserved.
Since the early 1980s, the adjunctive use of CPM has grown rapidly
to augment patients rehabilitation following TKA [13]. Reported
benets of CPM include facilitated improvements in range of motion,
decreased pain and swelling, reduced need for manipulation under
anesthesia, decreased hospital length of stay and a reduction in overall
cost. However, these benets remain controversial as the literature on
CPM has not conclusively conrmed these results since the initial
trials by Salter and colleagues [2,3]. For instance, research suggests
there are no long-term advantages associated with CPM use [48],
while other studies present no clinical differences between patients
given a CPM versus patients who complete standard physical therapy
alone [7,911].
The existing literature may be difcult to generalize and apply to
modern community practice. Multiple different CPM protocols have
been used and length of hospital stays had varied from 756 days. In
current practice, the average hospital stay following TKA has since
decreased to 3.5 days [12].
Additionally, not all studies specify the type of anesthetic and
prosthesis used, and whether or not the surgeries were performed by a
single surgeon or a team of surgeons under the same orthopedic unit.
Other variables loosely controlled include: discharge criteria, measures
of patient outcomes, and post-operative physical therapy protocols.
Methods
Study Design
This clinical study utilized a prospective, randomized, experimental design. Power analysis determined that a total sample size of
150, or 50 subjects in each group, would be needed to yield 81.74%
power to detect signicant differences in the dependent variables.
Participants
The Conict of Interest statement associated with this article can be found at
http://dx.doi.org/10.1016/j.arth.2013.12.005.
Reprint requests: Leslie Centeno, BA, Research Coordinator Miller Orthopedic
Specialists One Edmundson Place, Suite #500 Council Bluffs, IA 51503.
http://dx.doi.org/10.1016/j.arth.2013.12.005
0883-5403/ 2014 Elsevier Inc. All rights reserved.
1159
Procedure
The operating surgeon was blind to the randomization at the time
of surgery. All patients received a DePuy posterior stabilized knee
prosthesis with the majority under epidural anesthesia. While 47
patients in Group A, 43 patients in Group B, and 47 patients in Group C
received an epidural anesthetic, 7 patients in Group A, 8 patients in
Group B, and 7 patients in Group C received a general anesthetic.
Electrocautery and a pneumatic tourniquet were used for hemostasis
and Coumadin was administered as a postoperative anticoagulant.
Postoperative pain protocol consisted of Tylenol (1000 mg QID),
Tramadol (50 mg QID), Celebrex (400 mg pre-op, 200 mg BID post-
Outcome Measures
Prospective data collection included: change in hemoglobin from
the pre-operative period till the rst and second postoperative day;
self-reported pain scores 30 minutes prior to morning and afternoon
Table 1
Demographic Data Means and ANOVA Test Results.
Age (years)
Body mass index
Gender (% male)
10 cm above joint line (cm)a
At joint line (cm)a
10 cm below joint line (cm)a
Pre-op hemoglobin (gm/dl)b
Pre-op range of motion ()
a
b
Pre-operative girth.
Group B N = 50.
Group A
N = 55
Group B
N = 51
Group C
N = 54
P-Value
69.1
31.3
30.9
45.5
41.8
37.7
13.9
107.3
66.7
32.6
29.4
47.7
42.3
39.2
13.9
107.0
68.3
31.9
38.9
45.9
41.5
38.4
13.9
106.8
0.48
0.47
0.54
0.12
0.59
0.23
0.95
0.98
1160
Table 2
Day One Results.
Group A
N = 48
Group B
N = 47
Group C
N = 50
1.9
1.8
1.1
3.2
3.6
2.9
9.9
76.8
8.0
82.1
1.6
2.0
1.1
3.2
3.3
2.7
9.2
75.6
7.2
84.3
2.3
1.9
1.2
3.2
2.4
2.0
8.5
78.1
6.2
82.5
P-Value
0.40
0.96
0.94
0.98
0.13
0.09
0.37
0.62
0.14
0.58
0.65
Fig. 2. Knee extension.
Group A
N = 29
Group B
N = 25
Group C
N = 22
4.7
3.7
3.4
3.6
2.1
1.8
7.0
86.7
5.1
87.9
3.5
2.8
2.1
2.9
2.4
2.5
6.8
87.2
5.7
89.6
4.1
3.8
1.4
3.5
2.3
1.6
6.2
87.8
5.0
88.1
P-Value
0.31
0.34
b0.01*
0.07
0.91
0.14
0.82
0.92
0.79
0.77
0.06
Although many patients stayed longer than the second postoperative day, there were not enough inpatients to adequately
compare the groups past post-operative day two.
There were no signicant MANOVA test differences between the
groups for any variable.
The overall MANOVA test for range of motion, change in hemoglobin, girth measurements and pain scores were not signicant. (See
Tables 23 and Figs. 24). Evening pain scores were greatest in the
moving CPM group (Group A) and lowest in the no CPM group (Group
C), but was not statistically signicant. This was the most clinically
signicant nding for post-operative day one.
Drop in Hgb from pre-operative to post-operative day two was
lowest in Group B (goal of 90 degrees stationary CPM on the rst
post-operative night), although this difference was not statistically
signicant. During post-operative day two, Group A patients did show
a larger change in leg girth 10 cm below the joint line (P b .01). The
overall MANOVA test for length of stay was close to signicance at
0.09 (see Table 4). As the other four factors all had p-values ranging
from 0.940.96, the researchers conclude that the most signicant
difference between groups comes from the length of stay factor. The
raw values for length of stay (2.7, 3.2, and 2.6) days for Groups A, B,
and C, respectfully) show a clinically signicant difference (See
Table 4). The ANOVA test for length of stay showed a signicantly
longer stay for patients who received the stationary CPM (Group B) on
the rst night than for any other group (P b .01).
One patient in Group C and two patients in Group A underwent a
manipulation under anesthesia (See Table 5). No wound complications were seen in Group B, while one patient in Group A was admitted to the ER for swelling and one patient in Group C experienced a
hematoma. There were no signicant differences in the rate of complications between the groups.
Our institution rented 10 CPM devices at a time. Billing charges
indicate our institution was spending $1500 for the device rentals and
$350 for the accompanying software. Additionally, it cost $35 per hour
in labor for the nursing staff to apply, adjust, and monitor the CPM
device for an average of four hours.
Discussion
CPM provided no apparent benet to our patients recovering from
TKA in all outcome variables. We found no clinically signicant differences in ROM, swelling, blood loss, pain scores, or active ROM
achieved between any of the groups at any time.
Range of Motion
All treatment groups achieved similar ROM measurements in our
study. These results contradict reports of early increases in active ROM
with CPM use. McInnes and colleagues (1992) reported increases in
active exion by postoperative day seven after administering CPM on
1161
Table 4
Final Results.
Group A
N = 55
Group B
N = 51
Group C
N = 53
2.7
2.3
111.9
109.6
3.2
2.2
111.2
109.0
2.6
2.1
111.7
109.5
P-Value
b0.01b
0.94
0.94
0.96
0.09
Swelling
Blood Loss
Cost
Our institution was spending $1,850 for CPM device rentals and its
accompanying software. Patients were not billed for these devices, as
it was included in their hospital stay. If CPM devices were not included
in our post-operative rehabilitation protocol, our institution could
have saved $22,200 per year.
Conclusions
CPM use does not to appear to impact patients blood loss following TKA [7]. We similarly found no clinically signicant differ-
Pulmonary Embolism
Hypoxia
Headache
Hematoma
AFIB
Emergency Room Visit
Manipulation Under Anesthesia
Group A
N = 55
Group B
N = 51
Group C
N = 54
0
0
0
1
0
0
2
1
0
2
0
1
0
0
1
1
0
0
0
1
1
1162
5. Bequpr LA, Davies DM, Jones AC, et al. Exercise combined with continuous
passive motion or slider board therapy compared with exercise only: a
randomized controlled trial of patients following total knee arthroplasty. Phys
Ther 2000;81:1029.
6. Brosseau L, Mile S, Wells G, et al. Continuous passive motion following total knee
arthroplasty. J Rheumatol 2004;31(11):2251.
7. Lau S, Chiu K. Use of continuous passive motion after total knee arthroplasty.
J Arthroplasty 2001;16(3):336.
8. McInnes J, Larson MG, Daltroy LH, et al. A controlled evaluation of continuous
passive motion in patients undergoing total knee arthroplasty. JAMA 1992;
268(11):1423.
9. Davies DM, Johnston WC, Beaupre LA, et al. Effect of adjunctive range-of-motion
therapy after total knee arthroplasty on the use of health services after hospital
discharge. Can J Surg 2002;46(1):30.
10. Denis M, Moffet H, Caron F, et al. Effectiveness of continuous passive motion and
conventional physical therapy after total knee arthroplasty: a randomized clinical
trial. Phys Ther 2006;86(2):174.
11. Hewitt B, Shakespeare D. Flexion vs. extension: a comparison of post-operative
total knee arthroplasty mobilization regimes. Knee 2001;8:305.
12. Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR. Total Knee Arthroplasty Voume,
Utilization, and Outcomes Among Medicare Beneciaries, 19912010. JAMA
308(12);1227.
13. Lenssen TAF, Van Steyn MJA, Crijns YHF, Waltje EMH, Roox GM, Geesink RJT,
Van den Brandt PA, De Bie RA. BMC Musculoskelet Disord 9(60).
14. ODriscoll SW, Giori NJ. Continuous passive motion (CPM): theory and principles of
clinical application. J Rehabil Res Dev 2000;37(2):179.
15. Chen LH, Chen CH, Chien SH, et al. Aggressive continuous passive motion exercise
does not improve knee range of motion after total knee arthroplasty. J Clin Nurs
2012;22:389.
16. Polit DF, Beck CT. Nursing research: principles and methods. 7th ed.Philadelphia:
Lippincott Williams & Wilkins; 2004.
17. Montgomery F, Eliasson M. Continuous passive motion compared to active physical
therapy after knee arthroplasty. Acta Orthop Scand 1996;67(1):7.
18. Harms M, Engstrom B. Continuous passive motion as an adjunct to treatment in the
physiotherapy management of the total knee arthroplasty patient. Physiother
1991;77(4):301.
19. Pope R, Corcoran S, McCaul K, et al. Continuous passive motion after primary
total knee arthroplasty: does it offer any benets? J Bone Joint Surg Br 1997;
79-B(6):914.
20. Ritter MA, Gandolf VS, Holston KS. Continuous passive motion versus physical
therapy in total knee arthroplasty. Clin Orthop Relat Res 1989;244:239.